Merck logo

Merck

Last updated January 31, 2026
124
Innovation Areas
5,362
Inventors
47
Collaborations

Excessive postprandial hypoglycemia risk: MerckRecent Research Landscape

Full agonism of insulin receptors often leads to hypoglycemia and metabolic instability. Partial agonism provides a controlled glycemic response to prevent dangerous blood glucose drops.